201 related articles for article (PubMed ID: 20176998)
1. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways.
He H; Yang D; Ma L; Luo Z; Ma S; Feng X; Cao T; Yan Z; Liu D; Tepel M; Zhu Z
Hypertension; 2010 Apr; 55(4):869-79. PubMed ID: 20176998
[TBL] [Abstract][Full Text] [Related]
2. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells.
Mikami D; Kimura H; Kamiyama K; Torii K; Kasuno K; Takahashi N; Yoshida H; Iwano M
Hypertens Res; 2014 May; 37(5):422-31. PubMed ID: 24352213
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway.
Feng X; Luo Z; Ma L; Ma S; Yang D; Zhao Z; Yan Z; He H; Cao T; Liu D; Zhu Z
J Cell Mol Med; 2011 Jul; 15(7):1572-81. PubMed ID: 20477906
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
Fujisaka S; Usui I; Kanatani Y; Ikutani M; Takasaki I; Tsuneyama K; Tabuchi Y; Bukhari A; Yamazaki Y; Suzuki H; Senda S; Aminuddin A; Nagai Y; Takatsu K; Kobayashi M; Tobe K
Endocrinology; 2011 May; 152(5):1789-99. PubMed ID: 21427223
[TBL] [Abstract][Full Text] [Related]
6. Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.
Shiota A; Shimabukuro M; Fukuda D; Soeki T; Sato H; Uematsu E; Hirata Y; Kurobe H; Sakaue H; Nakaya Y; Masuzaki H; Sata M
Eur J Pharmacol; 2012 Oct; 692(1-3):84-90. PubMed ID: 22819702
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
[TBL] [Abstract][Full Text] [Related]
8. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
[TBL] [Abstract][Full Text] [Related]
9. Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
Kakuta H; Kurosaki E; Niimi T; Gato K; Kawasaki Y; Suwa A; Honbou K; Yamaguchi T; Okumura H; Sanagi M; Tomura Y; Orita M; Yonemoto T; Masuzaki H
J Pharmacol Exp Ther; 2014 Apr; 349(1):10-20. PubMed ID: 24424487
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice.
Araki K; Masaki T; Katsuragi I; Tanaka K; Kakuma T; Yoshimatsu H
Hypertension; 2006 Jul; 48(1):51-7. PubMed ID: 16717145
[TBL] [Abstract][Full Text] [Related]
12. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
[TBL] [Abstract][Full Text] [Related]
13. Increase of human prostate cancer cell (DU145) apoptosis by telmisartan through PPAR-delta pathway.
Wu TT; Niu HS; Chen LJ; Cheng JT; Tong YC
Eur J Pharmacol; 2016 Mar; 775():35-42. PubMed ID: 26852954
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
Aubert G; Burnier M; Dulloo A; Perregaux C; Mazzolai L; Pralong F; Zanchi A
Metabolism; 2010 Jan; 59(1):25-32. PubMed ID: 19793594
[TBL] [Abstract][Full Text] [Related]
15. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties.
Zanchi A; Dulloo AG; Perregaux C; Montani JP; Burnier M
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E91-5. PubMed ID: 17374699
[TBL] [Abstract][Full Text] [Related]
17. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta.
Yan ZC; Liu DY; Zhang LL; Shen CY; Ma QL; Cao TB; Wang LJ; Nie H; Zidek W; Tepel M; Zhu ZM
Biochem Biophys Res Commun; 2007 Mar; 354(2):427-33. PubMed ID: 17223076
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease.
Tong Q; Wu L; Jiang T; Ou Z; Zhang Y; Zhu D
Eur J Pharmacol; 2016 Apr; 776():106-15. PubMed ID: 26879867
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
